Health Care & Life Sciences » Biotechnology | Oncolys BioPharma Inc.

Oncolys BioPharma Inc.

Oncolys BioPharma Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY103.52
Market Cap
JPY28.93 B
Shares Outstanding
14.13 M
Public Float
11.46 M

Profile

Address
Toranomon Towers Office
Tokyo Tokyo 105
Japan
Employees -
Website http://www.oncolys.com
Updated 07/08/2019
Oncolys BioPharma, Inc. engages in the research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents. It also offers consulting services with regard to the research and development of biotechnology drugs. It operates through the following segments: Pharmaceutical and Diagnostics.

Financials

View All

Takashi Kamitani
Director & Head-Business Administration
Naoki Kobayashi
Director